Interventional pulmonology is a new field within pulmonary medicine focused on the use of advanced diagnostic and therapeutic techniques for patients with lung cancer, airway disorders, and pleural diseases.
Over the last few years our division has made a serious commitment of resources to be on the forefront of this exciting field of pulmonary medicine. Under the direction of Momen M. Wahidi, MD, MBA, the director of the Interventional Pulmonology Program, we now offer the most state-of-the-art treatments and therapies and are engaged in clinical research devoted to furthering the use of interventional pulmonology techniques.
Expert Technology, Exceptional Care
Our program has a dedicated bronchoscopy suite, fully equipped with the most advanced flexible bronchoscopic tools, fluoroscopy, digital imaging, and pathology support. The suite is staffed by full-time bronchoscopy staff with advanced nurses and respiratory therapists specifically dedicated to assisting with bronchoscopies.
We now offer more advanced flexible and rigid bronchoscopic techniques such as endobronchial ultrasound, electromagnetic navigation bronchoscopy, autofluorescence bronchoscopy, photodynamic therapy (PDT), endobronchial heat therapy (LASER and electrocautery), cryotherapy, brachytherapy and stent placement.
In the arena of pleural diseases, we offer ultrasound-guided thoracentesis, medical pleuroscopy, chest tube placement, and Pleurx catheter placement.
At Duke, the above techniques can be applied in a wide range of patients, including those patients with cancer involving the lung and/or pleura, lung and heart-lung transplant recipients, and those with a variety of airway and pleural disorders.
Our Interventional Pulmonology Program works closely with our thoracic surgery, oncology, radiation oncology, and radiology colleagues to provide comprehensive care to our patients.
Advancing the Use of Interventional Pulmonology
Our program is also actively engaged in basic and clinical research activities to advance our knowledge about the diagnosis and treatment of airway invasion by lung cancer and malignant pleural effusions.